During cortical development, neuronal progenitors proliferate and then migrate away from the ventricular zone (VZ) to take up residence in the cortical plate (CP). These immature cells take one of two paths upon exiting the VZ: 1) migrating directly along the radial glia scaffold to the CP, taking up residence in an inside out fashion or 2) they migrate to the subventricular zone (SVZ) and take on a multipolar morphology to become intermediate progenitors (IPs), undergo an additional round of cell division before continuing on their way to the CP. Although disruption in these events are known to contribute to pediatric neurodevelopmental disorders, the factors regulating progenitor retention in, and release from, unique neurogenic niches are not well understood. Small RhoGTPases, including cdc42 and RhoG, serve as regulators of progenitor proliferation and fate determination within the developing cortex. The mechanisms regulating RhoGTPases particularly in the developing nervous system, are not well understood. These regulators, comprised of GEFs and GAP) control the GTP-loading state, and thus activity, of RhoGTPases. Because GEFs act as activators for RhoGTPase, we hypothesize that GEFs are critical to RhoGTPase-mediated regulation of progenitor proliferation and fate determination in the developing cerebral cortex. We sought to identify GEFs with restricted expression in neurogenic niches of the developing cerebral cortex. Our efforts led us to a small guanine exchange factor (SGEF) whose expression is restricted to the VZ/SVZ during the peak of neurogenesis. SGEF is known to induce formation of F-actin rich protrusions on fibroblasts and endothelial cells (1-2). In support of a role for SGEF in the developing cerebral cortex, mice deficient in SGEF {SGEF^') exhibit reduced neural progenitor proliferation in the SVZ. We will use three aims to test our hypothesis:
Aim I : Can altered GEF expression mediate changes in the behavior of immature neurons? Aim II: Do GEFs selectively influence the proliferation and placement of neural progenitors? Aim III: By what mechanism(s) does SGEF regulate the developing cerebral cortex? These studies seek to uncover the mechanism and functional regulation of GEFs in the development of the mammalian cerebral cortex. By focusing on SGEF, whose expression is restricted to a defined neurogenic niche in the developing cerebral cortex and whose deletion appears to have nominal consequences outside of the central nervous system, we are able to use the developing cerebral cortex as a model to uncover clues about how GEFs function to regulate RhoGTPase signaling. '

Public Health Relevance

By defining these basic mechanisms of RhoGTPase regulation in the developing nervous system, we will provide crucial insight into neurodevelopment. Furthermore, by defining the mechanisms responsible for regulating neural progenitor proliferation, we might be able to manipulate these GEF-dependent processes in neuropediatric or neurodegenerative diseases to activate neuronal proliferation and differentiation.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
1P20GM103620-01A1
Application #
8465609
Study Section
Special Emphasis Panel (ZGM1-TWD-B (CB))
Project Start
Project End
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
1
Fiscal Year
2013
Total Cost
$295,573
Indirect Cost
$110,840
Name
Sanford Research/Usd
Department
Type
DUNS #
050113252
City
Sioux Falls
State
SD
Country
United States
Zip Code
57104
White, Katherine A; Swier, Vicki J; Cain, Jacob T et al. (2018) A porcine model of neurofibromatosis type 1 that mimics the human disease. JCI Insight 3:
Anderson, Ruthellen H; Lensing, Cody J; Forred, Benjamin J et al. (2018) Differentiating Antiproliferative and Chemopreventive Modes of Activity for Electron-Deficient Aryl Isothiocyanates against Human MCF-7 Cells. ChemMedChem 13:1695-1710
Johnson, Tyler B; Mechels, Keegan; Anderson, Ruth Ellen et al. (2018) Characterization of a recurrent missense mutation in the forkhead DNA-binding domain of FOXP1. Sci Rep 8:16161
Brudvig, J J; Cain, J T; Sears, R M et al. (2018) MARCKS regulates neuritogenesis and interacts with a CDC42 signaling network. Sci Rep 8:13278
Roux, Kyle J; Kim, Dae In; Burke, Brian et al. (2018) BioID: A Screen for Protein-Protein Interactions. Curr Protoc Protein Sci 91:19.23.1-19.23.15
Hussain, Sajjad; Bedekovics, Tibor; Liu, Qiuying et al. (2018) UCH-L1 bypasses mTOR to promote protein biosynthesis and is required for MYC-driven lymphomagenesis in mice. Blood 132:2564-2574
Brudvig, J J; Cain, J T; Schmidt-Grimminger, G G et al. (2018) MARCKS Is Necessary for Netrin-DCC Signaling and Corpus Callosum Formation. Mol Neurobiol 55:8388-8402
Anderson, Ruthellen H; Kerkvliet, Jason G; Otta, Jaelin J et al. (2018) Generation of a CLTA reporter human induced pluripotent stem cell line, CRMi001-A-1, using the CRISPR/Cas9 system to monitor endogenous clathrin trafficking. Stem Cell Res 33:95-99
Lucido, Christopher T; Callejas-Valera, Juan L; Colbert, Paul L et al. (2018) ?2-Adrenergic receptor modulates mitochondrial metabolism and disease progression in recurrent/metastatic HPV(+) HNSCC. Oncogenesis 7:81
McKenzie, Casey W; Preston, Claudia C; Finn, Rozzy et al. (2018) Strain-specific differences in brain gene expression in a hydrocephalic mouse model with motile cilia dysfunction. Sci Rep 8:13370

Showing the most recent 10 out of 59 publications